| Literature DB >> 25892619 |
Shuichi Hamada1, Wakako Ohyama2, Rie Takashima3, Keisuke Shimada4, Kazumi Matsumoto5, Satoru Kawakami6, Fuyumi Uno7, Hajime Sui8, Yasushi Shimada9, Tadashi Imamura10, Shoji Matsumura11, Hisakazu Sanada12, Kenji Inoue13, Shigeharu Muto14, Izumi Ogawa15, Aya Hayashi16, Tomomi Takayanagi17, Yosuke Ogiwara18, Akihisa Maeda19, Emiko Okada2, Yukari Terashima20, Hironao Takasawa3, Kazunori Narumi2, Yumi Wako3, Kazufumi Kawasako3, Masaki Sano7, Nobuyuki Ohashi7, Takeshi Morita21, Hajime Kojima21, Masamitsu Honma21, Makoto Hayashi7.
Abstract
The repeated-dose liver micronucleus (RDLMN) assay using young adult rats has the potential to detect hepatocarcinogens. We conducted a collaborative study to assess the performance of this assay and to evaluate the possibility of integrating it into general toxicological studies. Twenty-four testing laboratories belonging to the Mammalian Mutagenicity Study Group, a subgroup of the Japanese Environmental Mutagen Society, participated in this trial. Twenty-two model chemicals, including some hepatocarcinogens, were tested in 14- and/or 28-day RDLMN assays. As a result, 14 out of the 16 hepatocarcinogens were positive, including 9 genotoxic hepatocarcinogens, which were reported negative in the bone marrow/peripheral blood micronucleus (MN) assay by a single treatment. These outcomes show the high sensitivity of the RDLMN assay to hepatocarcinogens. Regarding the specificity, 4 out of the 6 non-liver targeted genotoxic carcinogens gave negative responses. This shows the high organ specificity of the RDLMN assay. In addition to the RDLMN assay, we simultaneously conducted gastrointestinal tract MN assays using 6 of the above carcinogens as an optional trial of the collaborative study. The MN assay using the glandular stomach, which is the first contact site of the test chemical when administered by oral gavage, was able to detect chromosomal aberrations with 3 test chemicals including a stomach-targeted carcinogen. The treatment regime was the 14- and/or 28-day repeated-dose, and the regime is sufficiently promising to incorporate these methods into repeated-dose toxicological studies. The outcomes of our collaborative study indicated that the new techniques to detect chromosomal aberrations in vivo in several tissues worked successfully.Entities:
Keywords: Gastrointestinal tract; Hepatocarcinogen; Integration; Liver; Micronucleus; Repeated-dose
Mesh:
Substances:
Year: 2015 PMID: 25892619 DOI: 10.1016/j.mrgentox.2015.01.001
Source DB: PubMed Journal: Mutat Res Genet Toxicol Environ Mutagen ISSN: 1383-5718 Impact factor: 2.873